Citations (77)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Martin Bastien, Salim Mezaache, Cécile Donadille, Victor Martin, Laurent Appel, Maela Lebrun, Laélia Briand Madrid, Tangui Barré & Perrine Roux. (2023) Exclusive Therapeutic Use of Cannabis in a Large Sample of Daily Cannabis Users in France: A Cross-Sectional Survey. Journal of Psychoactive Drugs 0:0, pages 1-11.
Read now
Read now
Olena Madden, Jessica Walshe, Prem Kishore Patnala, John Barron, Claire Meaney & Patrick Murray. (2023) Phytocannabinoids - An Overview of the Analytical Methodologies for Detection and Quantification of Therapeutically and Recreationally Relevant Cannabis Compounds. Critical Reviews in Analytical Chemistry 53:1, pages 211-231.
Read now
Read now
Barak Shapira, Ronny Berkovitz, Paola Rosca, Shaul Lev-Ran, Alexander Kaptsan & Yehuda Neumark. (2021) Why Switch? - Motivations for Self-Substitution of Illegal Drugs. Substance Use & Misuse 56:5, pages 627-638.
Read now
Read now
Mallory J E Loflin, Kimberly Babson, James Sottile, Sonya B Norman, Staci Gruber & Marcel O Bonn-Miller. (2019) A cross-sectional examination of choice and behavior of veterans with access to free medicinal cannabis. The American Journal of Drug and Alcohol Abuse 45:5, pages 506-513.
Read now
Read now
Thomas W. Wojciechowski. (2019) Developmental Trajectories of Opioid Use Among Juvenile Offenders: An Epidemiological Examination of Group Characteristics and Criminological Risk Factors. Substance Use & Misuse 54:7, pages 1203-1213.
Read now
Read now
Sara P Khan, Thomas A Pickens & Daniel J Berlau. (2019) Perspectives on Cannabis as a Substitute for Opioid Analgesics. Pain Management 9:2, pages 191-203.
Read now
Read now
Daniel J. Kruger & Jessica S. Kruger. (2019) Medical Cannabis Users’ Comparisons between Medical Cannabis and Mainstream Medicine. Journal of Psychoactive Drugs 51:1, pages 31-36.
Read now
Read now
Marc T. Swogger, Elaine Hart, Fire Erowid, Earth Erowid, Nicole Trabold, Kaila Yee, Kimberly A. Parkhurst, Brittany M. Priddy & Zach Walsh. (2015) Experiences of Kratom Users: A Qualitative Analysis. Journal of Psychoactive Drugs 47:5, pages 360-367.
Read now
Read now
Articles from other publishers (69)
Valérie GagnéNathalie BoucherIsabel Desgagné-Penix. (2024) Cannabis Roots: Therapeutic, Biotechnological and Environmental Aspects. Cannabis and Cannabinoid Research 9:1, pages 35-48.
Crossref
Crossref
Kelvin Le, Joanne Au, Jean Hua & Khang Duy Ricky Le. (2023) The Therapeutic Potential of Cannabidiol in Revolutionising Opioid Use Disorder Management. Cureus.
Crossref
Crossref
Calvin Diep, Akash Goel, Duminda N Wijeysundera, Hance Clarke & Karim S Ladha. (2023) Co-use of cannabis and prescription opioids in adults in the USA: a population-based, cross-sectional analysis of the NHANES from 2009 to 2018. Regional Anesthesia & Pain Medicine 48:4, pages 145-149.
Crossref
Crossref
Maha Hameed, Sakshi Prasad, Esha Jain, Bekir Nihat Dogrul, Ahmad Al-Oleimat, Bidushi Pokhrel, Selia Chowdhury, Edzel Lorraine Co, Saloni Mitra, Jonathan Quinonez, Samir Ruxmohan & Joel Stein. (2023) Medical Cannabis for Chronic Nonmalignant Pain Management. Current Pain and Headache Reports 27:4, pages 57-63.
Crossref
Crossref
Ediomo‐Ubong E. Nelson & Chenai Kitchen. (2022) Cannabis use for pain relief in the context of health service barriers: Accounts of street‐involved Nigerian women suffering chronic pain. Drug and Alcohol Review 42:2, pages 309-317.
Crossref
Crossref
Justin Sinclair & Mike Armour. 2023. Medicinal Usage of Cannabis and Cannabinoids. Medicinal Usage of Cannabis and Cannabinoids
483
494
.
Beatriz H. Carlini & Gillian L. Schauer. (2022) Cannabis-only use in the USA: prevalence, demographics, use patterns, and health indicators. Journal of Cannabis Research 4:1.
Crossref
Crossref
Islam Shehata, Ahmed Hashim, Ahmed Saad Elsaeidy, Anagha Nair, Ivan Urits, Omar Viswanath, Alan D. Kaye & Marian Habib. (2022) Cannabinoids and Their Role in Chronic Pain Treatment: Current Concepts and a Comprehensive Review. Health Psychology Research 10:4.
Crossref
Crossref
Michał Graczyk, Agata Anna Lewandowska, Piotr Melnyczok, Adam Zgliński & Małgorzata Łukowicz. (2022) Cannabinoids—Perspectives for Individual Treatment in Selected Patients: Analysis of the Case Series. Biomedicines 10:8, pages 1862.
Crossref
Crossref
Daniel J. Kruger, Majd A. MokbelDaniel J. ClauwKevin F. Boehnke. (2022) Assessing Health Care Providers' Knowledge of Medical Cannabis. Cannabis and Cannabinoid Research 7:4, pages 501-507.
Crossref
Crossref
Markus Köstenberger, Gerhard Nahler, Trevor M. Jones, Stefan Neuwersch & Rudolf Likar. (2021) The Role of Cannabis, Cannabidiol and Other Cannabinoids in Chronic Pain. The Perspective of Physicians. Journal of Neuroimmune Pharmacology 17:1-2, pages 318-333.
Crossref
Crossref
Richard L. Price, Kaarina V. Charlot, Sven Frieler, Joseph R. Dettori, Rod Oskouian & Jens R. Chapman. (2022) The Efficacy of Cannabis in Reducing Back Pain: A Systematic Review. Global Spine Journal 12:2, pages 343-352.
Crossref
Crossref
Jessica M. Potts, Betelihem Getachew, Milkie Vu, Eric Nehl, Katherine A. Yeager, Corinne R. Leach & Carla J Berg. (2020) Use and Perceptions of Opioids Versus Marijuana among Cancer Survivors. Journal of Cancer Education 37:1, pages 91-101.
Crossref
Crossref
William Dolphin & Michelle Newhart. 2022. Troubled Persons Industries. Troubled Persons Industries
245
287
.
Pradeep Kumar, Dipendra Kumar Mahato, Madhu Kamle, Rituraj Borah, Bharti Sharma, Shikha Pandhi, Vijay Tripathi, Hardeo Singh Yadav, Sheetal Devi, Umesh Patil, Jianbo Xiao & Awdhesh Kumar Mishra. (2021)
Pharmacological properties, therapeutic potential, and legal status of
Cannabis sativa
L.: An overview
. Phytotherapy Research 35:11, pages 6010-6029.
Crossref
Crossref
Hirak Shah, Meg Fraser, Arianne C. Agdamag, Valmiki Maharaj, Bellony Nzemenoh, Cindy M. Martin, Tamas Alexy & Daniel J. Garry. (2021) Cardiac Transplantation and the Use of Cannabis. Life 11:10, pages 1063.
Crossref
Crossref
Mike ArmourJustin SinclairGeoff NollerJane GirlingMaria LarcombeMahmoud A. Al-DabbasErika HollowDeborah BushNeil Johnson. (2021) Illicit Cannabis Usage as a Management Strategy in New Zealand Women with Endometriosis: An Online Survey. Journal of Women's Health 30:10, pages 1485-1492.
Crossref
Crossref
James Siklos-Whillans, Alia Bacchus & Laurie A. Manwell. (2020) A Scoping Review of the Use of Cannabis and Its Extracts as Potential Harm Reduction Strategies: Insights from Preclinical and Clinical Research. International Journal of Mental Health and Addiction 19:5, pages 1527-1550.
Crossref
Crossref
Miriam Boeri, Elise Pereira, Alina Minkova, Kevin Marcato, Elianne Martinez & Denise Woodall. (2020) Green Hope: Perspectives on Cannabis from People who Use Opioids. Sociological Inquiry 91:3, pages 668-695.
Crossref
Crossref
Rebecca Barmherzig & Thilinie Rajapakse. (2021) Nutraceuticals and Behavioral Therapy for Headache. Current Neurology and Neuroscience Reports 21:7.
Crossref
Crossref
Lauren R. Gorfinkel, Malki Stohl, Eliana Greenstein, Efrat Aharonovich, Mark Olfson & Deborah Hasin. (2020) Is Cannabis being used as a substitute for non‐medical opioids by adults with problem substance use in the United States? A within‐person analysis. Addiction 116:5, pages 1113-1121.
Crossref
Crossref
Faris Khan & Aman Mehan. (2021) Addressing opioid tolerance and opioid‐induced hypersensitivity: Recent developments and future therapeutic strategies. Pharmacology Research & Perspectives 9:3.
Crossref
Crossref
Brandon R. McFadden & Trey Malone. (2021) Homegrown perceptions about the medical use and potential abuse of CBD and THC. Addictive Behaviors 115, pages 106799.
Crossref
Crossref
Michał Graczyk, Małgorzata Łukowicz & Tomasz Dzierzanowski. (2021) Prospects for the Use of Cannabinoids in Psychiatric Disorders. Frontiers in Psychiatry 12.
Crossref
Crossref
Cesar D. Lopez, Venkat Boddapati, Charles M. Jobin & Thomas R. Hickernell. (2021) State Medical Cannabis Laws Associated With Reduction in Opioid Prescriptions by Orthopaedic Surgeons in Medicare Part D Cohort. Journal of the American Academy of Orthopaedic Surgeons 29:4, pages e188-e197.
Crossref
Crossref
Rachel Carmen Ceasar, Alex H. Kral, Kelsey Simpson, Lynn Wenger, Jesse L. Goldshear & Ricky N. Bluthenthal. (2021) Factors associated with health-related cannabis use intentions among a community sample of people who inject drugs in Los Angeles and San Francisco, CA 2016 to 2018. Drug and Alcohol Dependence 219, pages 108421.
Crossref
Crossref
Laurel P. Gibson, Leah N. Hitchcock, Angela D. Bryan & L. Cinnamon Bidwell. (2021) Experience of migraine, its severity, and perceived efficacy of treatments among cannabis users. Complementary Therapies in Medicine 56, pages 102619.
Crossref
Crossref
Barak Shapira, Paola Rosca, Ronny Berkovitz, Igor Gorjaltsan & Yehuda Neumark. (2020) The switch from one substance-of-abuse to another: illicit drug substitution behaviors in a sample of high-risk drug users. PeerJ 8, pages e9461.
Crossref
Crossref
Jenna Valleriani, Rebecca Haines-Saah, Rielle Capler, Ricky Bluthenthal, M. Eugenia Socias, MJ Milloy, Thomas Kerr & Ryan McNeil. (2020) The emergence of innovative cannabis distribution projects in the downtown eastside of Vancouver, Canada. International Journal of Drug Policy 79, pages 102737.
Crossref
Crossref
Dan Jin, Kaiping Dai, Zhen Xie & Jie Chen. (2020) Secondary Metabolites Profiled in Cannabis Inflorescences, Leaves, Stem Barks, and Roots for Medicinal Purposes. Scientific Reports 10:1.
Crossref
Crossref
E.Gy Bán, A. Brassai & E.S. Vizi. (2020) The role of the endogenous neurotransmitters associated with neuropathic pain and in the opioid crisis: The innate pain-relieving system. Brain Research Bulletin 155, pages 129-136.
Crossref
Crossref
Courtney T Blondino, Mirinda Ann Gormley, DaShaunda D H Taylor, Elizabeth Lowery, James S Clifford, Benjamin Burkart, Whitney C Graves, Juan Lu & Elizabeth C Prom-Wormley. (2020) The Influence of Co-Occurring Substance Use on the Effectiveness of Opiate Treatment Programs According to Intervention Type. Epidemiologic Reviews 42:1, pages 57-78.
Crossref
Crossref
Philippe Lucas, Eric P. Baron & Nick Jikomes. (2019) Medical cannabis patterns of use and substitution for opioids & other pharmaceutical drugs, alcohol, tobacco, and illicit substances; results from a cross-sectional survey of authorized patients. Harm Reduction Journal 16:1.
Crossref
Crossref
Jamie L. Flexon, Lisa Stolzenberg & Stewart J. D'Alessio. (2019) The effect of cannabis laws on opioid use. International Journal of Drug Policy 74, pages 152-159.
Crossref
Crossref
Christoph Wendelmuth & Knud Gastmeier. (2019) Hochdosisdronabinoltherapie vs. MedizinalcannabisblütenHigh-dose dronabinol treatment vs. medicinal cannabis flowers. Der Schmerz 33:5, pages 392-398.
Crossref
Crossref
Justin C. Strickland, Joshua A. Lile & William W. Stoops. (2019) Evaluating non-medical prescription opioid demand using commodity purchase tasks: test-retest reliability and incremental validity. Psychopharmacology 236:9, pages 2641-2652.
Crossref
Crossref
Yuyan Shi, Di Liang, Yuhua Bao, Ruopeng An, Mark S. Wallace & Igor Grant. (2019) Recreational marijuana legalization and prescription opioids received by Medicaid enrollees. Drug and Alcohol Dependence 194, pages 13-19.
Crossref
Crossref
Wajd Alkabbani, Ruth Ann Marrie, Shawn Bugden, Silvia Alessi-Severini, Paul Daeninck, James Bolton, Jitender Sareen & Christine Leong. (2018) Pharmaceutical cannabinoid use in Manitoba, 2004/05 to 2014/15: a population-based cross-sectional study. CMAJ Open 6:4, pages E637-E642.
Crossref
Crossref
David J DiBenedetto, Valerie F Weed, Kelly M Wawrzyniak, Matthew Finkelman, Jenelle Paolini, Michael E Schatman, David Herrera & Ronald J Kulich. (2018) The Association Between Cannabis Use and Aberrant Behaviors During Chronic Opioid Therapy for Chronic Pain. Pain Medicine 19:10, pages 1997-2008.
Crossref
Crossref
Kara Manning, Andrew H. Rogers, Jafar Bakhshaie, Julianna B.D. Hogan, Julia D. Buckner, Joseph W. Ditre & Michael J. Zvolensky. (2018) The association between perceived distress tolerance and cannabis use problems, cannabis withdrawal symptoms, and self-efficacy for quitting cannabis: The explanatory role of pain-related affective distress. Addictive Behaviors 85, pages 1-7.
Crossref
Crossref
Ahmet Goktan AksuOzgur GunduzAhmet Ulugol. (2018)
Contribution of spinal 5-HT
5A
receptors to the antinociceptive effects of systemically administered cannabinoid agonist WIN 55,212-2 and morphine
. Canadian Journal of Physiology and Pharmacology 96:6, pages 618-623.
Crossref
Crossref
Marcus A. BachhuberJulia H. ArnstenJoanna L. StarrelsChinazo O. Cunningham. (2018) Willingness to Participate in Longitudinal Research Among People with Chronic Pain Who Take Medical Cannabis: A Cross-Sectional Survey. Cannabis and Cannabinoid Research 3:1, pages 45-53.
Crossref
Crossref
Douglas BruceJohn P. BradyElissa FosterMona Shattell. (2018) Preferences for Medical Marijuana over Prescription Medications Among Persons Living with Chronic Conditions: Alternative, Complementary, and Tapering Uses. The Journal of Alternative and Complementary Medicine 24:2, pages 146-153.
Crossref
Crossref
Brian Hainline, Wayne Derman, Alan Vernec, Richard Budgett, Masataka Deie, Jiří Dvořák, Chris Harle, Stanley A Herring, Mike McNamee, Willem Meeuwisse, G Lorimer Moseley, Bade Omololu, John Orchard, Andrew Pipe, Babette M Pluim, Johan Ræder, Christian Siebert, Mike Stewart, Mark Stuart, Judith A Turner, Mark Ware, David Zideman & Lars Engebretsen. (2017) International Olympic Committee consensus statement on pain management in elite athletes. British Journal of Sports Medicine 51:17, pages 1245-1258.
Crossref
Crossref
Rudolf LikarGerhard Nahler. (2017) The use of cannabis in supportive care and treatment of brain tumor. Neuro-Oncology Practice 4:3, pages 151-160.
Crossref
Crossref
Benjamin J. Morasco, Bobbi Jo Yarborough, Ning X. Smith, Steven K. Dobscha, Richard A. Deyo, Nancy A. Perrin & Carla A. Green. (2017) Higher Prescription Opioid Dose is Associated With Worse Patient-Reported Pain Outcomes and More Health Care Utilization. The Journal of Pain 18:4, pages 437-445.
Crossref
Crossref
Philippe Lucas & Zach Walsh. (2017) Medical cannabis access, use, and substitution for prescription opioids and other substances: A survey of authorized medical cannabis patients. International Journal of Drug Policy 42, pages 30-35.
Crossref
Crossref
Victoria Kostadinov & Ann Roche. (2016) Bongs and baby boomers: Trends in cannabis use among older Australians. Australasian Journal on Ageing 36:1, pages 56-59.
Crossref
Crossref
Zach Walsh, Raul Gonzalez, Kim Crosby, Michelle S. Thiessen, Chris Carroll & Marcel O. Bonn-Miller. (2017) Medical cannabis and mental health: A guided systematic review. Clinical Psychology Review 51, pages 15-29.
Crossref
Crossref
Amanda ReimanMark WeltyPerry Solomon. (2017) Cannabis as a Substitute for Opioid-Based Pain Medication: Patient Self-Report. Cannabis and Cannabinoid Research 2:1, pages 160-166.
Crossref
Crossref
A. Helander. 2017. Handbook of Cannabis and Related Pathologies. Handbook of Cannabis and Related Pathologies
839
847
.
Ahmet Ulugol, Ruhan D. Topuz, Ozgur Gunduz, Gulnur Kizilay & Hakan C. Karadag. (2016)
Changes in nociceptin/orphanin
FQ
levels in rat brain regions after acute and chronic cannabinoid treatment in conjunction with the development of antinociceptive tolerance
. Fundamental & Clinical Pharmacology 30:6, pages 537-548.
Crossref
Crossref
Yuval ZolotovYehuda BaruchHaim ReuveniRacheli Magnezi. (2016) Adherence to Medical Cannabis Among Licensed Patients in Israel. Cannabis and Cannabinoid Research 1:1, pages 16-21.
Crossref
Crossref
Adam R. Toth, Carl J. Possidente, Linda M. Sawyer, Mark A. DiParlo & Gilbert J. Fanciullo. (2016) National and Northern New England Opioid Prescribing Patterns, 2013–2014. Pain Medicine, pages pnw231.
Crossref
Crossref
Ernest Small. 2016. Cannabis. Cannabis
229
252
.
Philippe Lucas, Zach Walsh, Kim Crosby, Robert Callaway, Lynne Belle‐Isle, Robert Kay, Rielle Capler & Susan Holtzman. (2015) Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors. Drug and Alcohol Review 35:3, pages 326-333.
Crossref
Crossref
. (2016) Integrative Approaches to Chronic Pain: A Clinical Conversation with Robert Bonakdar, MD, FAAFP, and Robert Rountree, MD. Alternative and Complementary Therapies 22:2, pages 43-49.
Crossref
Crossref
O. Gunduz, R.D. Topuz, C.H. Karadag & A. Ulugol. (2015) Analysis of the anti‐allodynic effects of combination of a synthetic cannabinoid and a selective noradrenaline re‐uptake inhibitor in nerve injury‐induced neuropathic mice. European Journal of Pain 20:3, pages 465-471.
Crossref
Crossref
Scott P. Novak, Nicholas C. Peiper & Gary A. Zarkin. (2016) Nonmedical prescription pain reliever and alcohol consumption among cannabis users. Drug and Alcohol Dependence 159, pages 101-108.
Crossref
Crossref
Nicholas Lau, Paloma Sales, Sheigla Averill, Fiona Murphy, Sye‐Ok Sato & Sheigla Murphy. (2015) A safer alternative: Cannabis substitution as harm reduction. Drug and Alcohol Review 34:6, pages 654-659.
Crossref
Crossref
Pauline Voon. (2015) Further defining and conceptualizing opioid misuse in chronic pain. Pain 156:10, pages 2107.
Crossref
Crossref
Alex H. Kral, Lynn Wenger, Scott P. Novak, Daniel Chu, Karen F. Corsi, Diana Coffa, Brad Shapiro & Ricky N. Bluthenthal. (2015) Is cannabis use associated with less opioid use among people who inject drugs?. Drug and Alcohol Dependence 153, pages 236-241.
Crossref
Crossref
David Tauben. (2015) Nonopioid Medications for Pain. Physical Medicine and Rehabilitation Clinics of North America 26:2, pages 219-248.
Crossref
Crossref
Donald E. Greydanus, Gabriel Kaplan, Louis E. BaxterSrSr, Dilip R. Patel & Cynthia L. Feucht. (2015) Cannabis: The never-ending, nefarious nepenthe of the 21st century: What should the clinician know?. Disease-a-Month 61:4, pages 118-175.
Crossref
Crossref
Thiago Wendt Viola, Saulo Gantes Tractenberg, Luis Eduardo Wearick-Silva, Caroline Silva de Oliveira Rosa, Júlio Carlos Pezzi & Rodrigo Grassi-Oliveira. (2014) Long-term cannabis abuse and early-onset cannabis use increase the severity of cocaine withdrawal during detoxification and rehospitalization rates due to cocaine dependence. Drug and Alcohol Dependence 144, pages 153-159.
Crossref
Crossref
Lynne Belle-Isle, Zach Walsh, Robert Callaway, Philippe Lucas, Rielle Capler, Robert Kay & Susan Holtzman. (2014) Barriers to access for Canadians who use cannabis for therapeutic purposes. International Journal of Drug Policy 25:4, pages 691-699.
Crossref
Crossref
J. Michael Bostwick. (2014) The use of cannabis for management of chronic pain. General Hospital Psychiatry 36:1, pages 2-3.
Crossref
Crossref
Neil P. Johnson, Lone Hummelshoj, M.S. Abrao, G.D. Adamson, C. Allaire, V. Amelung, E. Andersson, C. Becker, K.B. Birna Árdal, D. Bush, B. de Bie, K. Chwalisz, H. Critchley, T. D'Hooghe, G. Dunselman, J.L.H. Evers, C. Farquhar, T. Faustmann, A. Forman, J. Fourquet, I. Fraser, L. Giudice, S. Gordts, H. Guidone, S.W. Guo, D. Healy, B. Hedon, J. Hulkkonen, L. Hull, L. Hummelshoj, N.P. Johnson, M. Just, L. Kiesel, A. Lam, C. Lynam, L. Mettler, C. Miller, H. North, R. Pai, C. Petta, L. Prentice, S. Reilly, F. Reis, E. Rolla, L. Rombauts, K.W. Schweppe, T. Seckin, K. Sharpe-Timms, D. Shepperson Mills, S. Singh, D. Soriano, M. Stafford-Bell, P. Stratton, R. Taylor, J. Tsaltas, J. Veit & P. Vercellini. (2013) Consensus on current management of endometriosis. Human Reproduction 28:6, pages 1552-1568.
Crossref
Crossref
Natascha Leleu-Chavain, Christophe Biot, Philippe Chavatte & Régis Millet. (2013)
Du cannabis aux agonistes sélectifs du récepteur CB
2
. médecine/sciences 29:5, pages 523-528.
Crossref
Crossref